Similar to our results, therapeutic modulation of myeloid polarization through the IFN-γR/STAT1 signaling axis was found to enhance antitumor immune function by activating tumor infiltrating myeloid cells, regulating PD-L1 expression, and promoting immunogenic cell death [53,54,55,56,57,58]. Here, STAT1 is linked to neoplasm.